Showing results (501-510 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|January 19, 2026
In silico evaluation of procyanidin as a potential ESR1 inhibitor: docking and MD insights in uterine fibroids and endometriosisZahra Maravandi, Sahar Gholamian, Ali Samadi, et al.
In Silico Pharmacology|December 1, 2025
Network pharmacology prediction of UA in targeting endometriosis progression to endometrial cancerJayhind Kumar Chauhan, Pradeep Kumar, Sangeeta Rai, et al.
In Silico Pharmacology|December 1, 2025
Insilico pharmacological profiling of Endostemon viscosus bioactive compounds targeting MMP-9 for wound healingKavi Malar Surendran, Saradha Maran, Sugandhi Pugazhendhi
In Silico Pharmacology|November 24, 2025
Targeting the core: C9ORF72 antagonists as pioneers in amyotrophic lateral sclerosis therapy-a computational and machine learning based approachK T Nachammai, P Sangavi, Chitra Sekar, et al.
In Silico Pharmacology|November 24, 2025
In silico and in vitro evaluation of flavonoid derivatives for diabetes management: molecular dynamics, and enzyme kinetics for pancreatic alpha-amylase and alpha-glucosidaseJamie McMillan, Megan Jean Bester, Zeno Apostolides
In Silico Pharmacology|November 24, 2025
Computational profiling of flavonoids against key breast cancer targets: an in-silico explorationS A Praise, M M Olusanya, A T Kolawole, et al.
In Silico Pharmacology|November 24, 2025
Drug repurposing for type 2 diabetes: computational studies of potential alpha-glucosidase inhibitors from DrugBankAdeshina I Odugbemi, Samson O Oselusi, Janet Kalu, et al.
In Silico Pharmacology|November 24, 2025
Computational screening and molecular dynamics simulation of flavonoids from Mentha arvensis as potential alpha-glucosidase inhibitors for type 2 diabetes mellitusKrati Tiwari, Vivek Dhar Dwivedi, Indra Prasad Tripathi
In Silico Pharmacology|December 8, 2025
Exploring the anticancer potential of Tinospora cordifolia with computational insights into EGFR inhibitionG Asha, S Lekshmi, K P Najmathunnisa, et al.
In Silico Pharmacology|November 17, 2025
Isolation and characterization of a potent anticancer fraction from Clinacanthus nutans targeting MCF-7 and A549 cells: an integrated in vitro and in silico studySushma Jahagirdar, Smitha S Bhat, R Sindhu, et al.
Pageof 79